Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.

F Dumetz, B Cuypers, H Imamura, D Zander, E D'Haenens, I Maes, M A Domagalska, J Clos, J-C Dujardin, G De Muylder

Journal: mSphere 2019;3(2):0

PMID: 29669889

Abstract

Antimonials (Sb) were used for decades for chemotherapy of visceral leishmaniasis (VL). Now abandoned in the Indian subcontinent (ISC) because of resistance, this drug offers a unique model for understanding drug resistance dynamics. In a previous phylogenomic study, we found two distinct populations of : the core group (CG) in the Gangetic plains and ISC1 in the Nepalese highlands. Sb resistance was only encountered within the CG, and a series of potential markers were identified. Here, we analyzed the development of resistance to trivalent antimonials (Sb) upon experimental selection in ISC1 and CG strains. We observed that (i) baseline Sb susceptibility of parasites was higher in ISC1 than in the CG, (ii) time to Sb resistance was higher for ISC1 parasites than for CG strains, and (iii) untargeted genomic and metabolomic analyses revealed molecular changes along the selection process: these were more numerous in ISC1 than in the CG. Altogether these observations led to the hypothesis that CG parasites are preadapted to Sb resistance. This hypothesis was experimentally confirmed by showing that only wild-type CG strains could survive a direct exposure to the maximal concentration of Sb The main driver of this preadaptation was shown to be , a gene involved in Sb sequestration and amplified in an intrachromosomal amplicon in all CG strains characterized so far. This amplicon emerged around 1850 in the CG, well before the implementation of antimonials for VL chemotherapy, and we discuss here several hypotheses of selective pressure that could have accompanied its emergence. The "antibiotic resistance crisis" is a major challenge for scientists and medical professionals. This steady rise in drug-resistant pathogens also extends to parasitic diseases, with antimony being the first anti- drug that fell in the Indian subcontinent (ISC). Leishmaniasis is a major but neglected infectious disease with limited therapeutic options. Therefore, understanding how parasites became resistant to antimonials is of commanding importance. In this study, we experimentally characterized the dynamics of this resistance acquisition and show for the first time that some populations of the ISC were preadapted to antimony resistance, likely driven by environmental factors or by drugs used in the 19th century.

Copyright © 2018 Dumetz et al.

Address: Molecular Parasitology, Institute of Tropical Medicine, Antwerp, Belgium.; Advanced Database Reasearch and Modelling (ADReM), Department of Mathematics and Computer Science, University of Antwerp, Antwerp, Belgium.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Molecular Parasitology, Institute of Tropical Medicine, Antwerp, Belgium [email protected] [email protected].; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.